Larisch R, Klimke A, Mayoral F, Hamacher K, Herzog H R, Vosberg H, Tosch M, Gaebel W, Rivas F, Coenen H H, Müller-Gärtner H W
Kliniken für Nuklearmedizin, Heinrich-Heine-Universität, Düsseldorf, Deutschland.
Nuklearmedizin. 2001 Aug;40(4):129-34.
The characteristics of 5HT2 receptor binding were investigated in major depression in vivo using positron emission tomography and the radioligand F-18-altanserin.
Twelve patients from families with high loading of depression living in a geographically restricted region were examined and compared with normal control subjects. At the time of the PET measurement all patients were remitted; in some of them remission was sustained by antidepressive medication. Binding potential was assessed by Logan's graphical analysis method.
The binding of F-18-altanserin was about 38% lower in patients than in healthy controls (p < 0.001). A multiple regression analysis revealed that this difference was mainly induced by depression rather than by medication.
The data suggest that 5HT2 receptors are altered in depression. We present evidence for a reduction of the receptor density, which might be usable as trait marker of subjects susceptible for depressive illness.